Sangamo Biosciences (SGMO) Tops Q3 EPS by 4c, Revs Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Sangamo Therapeutics Reports Third Quarter 2017 Financial Results
November 9, 2017 4:01 PM ESTRICHMOND, Calif., Nov. 9, 2017 /PRNewswire/ --Â Sangamo Therapeutics, Inc. (NASDAQ: SGMO) today reported its third quarter 2017 financial results and recent accomplishments.
"We continue to make progress on the key priorities we laid out at the beginning of 2017," said Dr. Sandy... More
